Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 14 (RPL21P14)

Target: RPL21P14
Molecular classification: Other

Overview

Ribosomal protein L21 pseudogene 14 (RPL21P14) is a pseudogene in humans and does not code for a functional protein. It resembles the gene for ribosomal protein L21 but lacks protein-coding potential and biological activity. There is no evidence that it acts as a therapeutic target, disease gene, or drug interaction site. It is one of several processed pseudogenes derived from the functional ribosomal protein L21 gene, and is not associated with any known disease or cellular function[2][5][6][7].

Other names: HsT16795RPL21_53_1436

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 14 (RPL21P14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 14 (RPL21P14).

Explore the full profile